Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

SRPT Relative to the S&P 500

SRPT Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Sarepta Therapeutics, Inc. (NASD:SRPT) seasonal charts above shows that a Buy Date of July 10 and a Sell Date of October 3 has resulted in a geometric average return of 18.91% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 29.2% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

To download SRPT seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: SRPT